Prognostic influence of clinical biomarkers in patients (pts) with advanced hepatocellular carcinoma (HCC) receiving sorafenib; a single institution experience

O Abdel-Rahman, A Lamarca, I Salu, Mairead Mcnamara, JW Valle, RA Hubner

    Research output: Contribution to conferencePoster

    Fingerprint

    Dive into the research topics of 'Prognostic influence of clinical biomarkers in patients (pts) with advanced hepatocellular carcinoma (HCC) receiving sorafenib; a single institution experience'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Nursing and Health Professions

    Pharmacology, Toxicology and Pharmaceutical Science